With the increase in trade volume, the price of Spherix Incorporated (SPEX) has increased significantly in last two weeks. If we recall we find that on February 04, 2013 the closing price of SPEX stock was only $5.51, which was to $13.20 on March 07, 2013. The stock price is in upward trend. Following this, investors are seeking answer why the unusual price increase happened. The probable answer is that the company has put effort to recover its slow financial performance by recent business deal with international parties, major restructuring or divestment, appointment of new CEO, etc. The company has announced its progress to sign agreement with Fulllife Health care Pvt. Ltd, an innovation driven company focused on bringing healthcare solutions to India. This agreement will facilitate to supply and license agreement for the use of D-tagatose nutraceutical products in India. As part of its penetration to international market, the above dealing may bring good operating result for the company. The company has raised $2.6 million fund through private placement to strengthen its capital structure. The above has been reflected in the market price SPEX stock. Mean while, SPEX has gone for divestment of one of its subsidiary companies named Spherix Consulting, Inc. to ensure more focus on its main operation, which perhaps has been considered positively by the investors. Moreover, the company has appointed Mr. Harvey Kesner as its Chief executive officer, which has made major impact in the market. It is most likely that the investors are foreseeing a better future of SPEX within short time. The company may show better operating result in the upcoming period. The above has been reflected in the market. Also, the company has reported comparatively better financial result in individual 3rd quarter in 2012 from 3rd quarter in 2011. It is also spread that the company is going to report a little better result in 4rth quarter too.